share_log

Biomerica | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Biomerica | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Biomerica | PRE 14A：並購重組委托聲明
美股SEC公告 ·  09/20 17:03
Moomoo AI 已提取核心訊息
Biomerica, Inc. announced the initiation of a reverse stock split and an increase in authorized shares, subject to stockholder approval. The reverse stock split, at a ratio not less than 1-for-3 and not more than 1-for-15, aims to elevate the per-share trading price to comply with Nasdaq's minimum bid requirement and to attract a broader investor base. The company also seeks to increase authorized common stock from 25 million to 40 million shares, enhancing its ability to raise capital and pursue strategic opportunities. These proposals are part of the agenda for Biomerica's upcoming annual meeting of stockholders, where votes will be cast to determine the outcome. The Board may decide not to proceed with the reverse stock split or the increase in authorized shares if deemed not in the best interest of the company or its stockholders.
Biomerica, Inc. announced the initiation of a reverse stock split and an increase in authorized shares, subject to stockholder approval. The reverse stock split, at a ratio not less than 1-for-3 and not more than 1-for-15, aims to elevate the per-share trading price to comply with Nasdaq's minimum bid requirement and to attract a broader investor base. The company also seeks to increase authorized common stock from 25 million to 40 million shares, enhancing its ability to raise capital and pursue strategic opportunities. These proposals are part of the agenda for Biomerica's upcoming annual meeting of stockholders, where votes will be cast to determine the outcome. The Board may decide not to proceed with the reverse stock split or the increase in authorized shares if deemed not in the best interest of the company or its stockholders.
biomerica公司宣佈啓動股票逆拆分並增加授權股票數量，需股東批准。逆向股票拆分比例不低於1股兌3股，不高於1股兌15股，旨在提高每股交易價格以符合納斯達克的最低買盤要求，並吸引更廣泛的投資者群體。公司還計劃將授權普通股數量從2500萬份增加到4000萬份，增強籌集資本和追求戰略機會的能力。這些提議是biomerica即將舉行的股東大會議程的一部分，屆時將投票決定結果。如果董事會認爲逆向股票拆分或增加授權股份不符合公司或股東最佳利益，可能決定不繼續進行。
biomerica公司宣佈啓動股票逆拆分並增加授權股票數量，需股東批准。逆向股票拆分比例不低於1股兌3股，不高於1股兌15股，旨在提高每股交易價格以符合納斯達克的最低買盤要求，並吸引更廣泛的投資者群體。公司還計劃將授權普通股數量從2500萬份增加到4000萬份，增強籌集資本和追求戰略機會的能力。這些提議是biomerica即將舉行的股東大會議程的一部分，屆時將投票決定結果。如果董事會認爲逆向股票拆分或增加授權股份不符合公司或股東最佳利益，可能決定不繼續進行。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息